Source: ALL
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
partner and localizer of BRCA2 | 0.485 | 0.769 | 3.0E-19 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
BRCA1 interacting protein C-terminal helicase 1 | 0.507 | 0.731 | 6.2E-17 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group M | 0.543 | 0.731 | 2.4E-15 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FAT atypical cadherin 4 | 0.539 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
collagen and calcium binding EGF domains 1 | 0.585 | 0.769 | 1.5E-07 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
X-ray repair cross complementing 2 | 0.512 | 0.731 | 4.0E-07 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
von Hippel-Lindau tumor suppressor | 0.443 | 0.846 | 8.0E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
SLX4 structure-specific endonuclease subunit | 0.565 | 0.731 | 1.6E-22 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 3 | 0.581 | 0.808 | 1.0E-10 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ADP ribosylation factor like GTPase 6 interacting protein 6 | 0.686 | 0.615 | 1.8E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
mitotic arrest deficient 2 like 2 | 0.547 | 0.731 | 8.2E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
endoglin | 0.446 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 43 | 2 | 1996 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1996 | 2020 | ||||||||
|
fibronectin 1 | 0.365 | 0.962 | 1.4E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
endothelin 1 | 0.380 | 0.846 | 0.46 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1997 | 2006 | ||||||||
|
endothelin receptor type A | 0.426 | 0.885 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
transforming growth factor beta 3 | 0.498 | 0.808 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
transforming growth factor beta 2 | 0.433 | 0.885 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.050 | None | 1.000 | 5 | 1 | 1999 | 2018 | ||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 1999 | 2017 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
ETS proto-oncogene 1, transcription factor | 0.444 | 0.731 | 0.78 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
activin A receptor like type 1 | 0.493 | 0.769 | 9.7E-04 |
|
disease | 0.100 | None | 0.977 | 43 | 0 | 2000 | 2020 |